{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:31:52Z","timestamp":1757453512797,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12194-025-00895-1","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T17:59:37Z","timestamp":1741975177000},"page":"451-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential of the albumin\u2013bilirubin score to predict the hepatic parenchymal contrast enhancement in the portal phase of abdominal dynamic contrast-enhanced multi-detector computed tomography in patients with liver cirrhosis"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-0315","authenticated-orcid":false,"given":"Yasuhiro","family":"Inokuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromasa","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"895_CR1","unstructured":"ACR. https:\/\/www.acr.org\/Quality-Safety\/Resources\/LIRADS. Accessed July 8, 2021"},{"issue":"3","key":"895_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/ajg.2009.663","volume":"105","author":"M Sherman","year":"2010","unstructured":"Sherman M. The radiological diagnosis of hepatocellular carcinoma. Am J Gastroenterol. 2010;105(3):610\u20132. https:\/\/doi.org\/10.1038\/ajg.2009.663.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"895_CR3","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1148\/radiology.216.3.r00se26718","volume":"216","author":"Y Yamashita","year":"2000","unstructured":"Yamashita Y, Komohara Y, Takahashi M, Uchida M, Hayabuchi M, Shimizu T, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material\u2014a prospective randomized study. Radiology. 2000;216(3):718\u201323. https:\/\/doi.org\/10.1148\/radiology.216.3.r00se26718.","journal-title":"Radiology"},{"issue":"3","key":"895_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1148\/radiol.2333031617","volume":"233","author":"K Awai","year":"2004","unstructured":"Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology. 2004;233(3):682\u20138. https:\/\/doi.org\/10.1148\/radiol.2333031617.","journal-title":"Radiology"},{"issue":"4","key":"895_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11604-015-0398-1","volume":"33","author":"G Koiwahara","year":"2015","unstructured":"Koiwahara G, Tsuda T, Matsuda M, Hirata M, Tanaka H, Hyodo T, et al. Different enhancement of the hepatic parenchyma in dynamic CT for patients with normal liver and chronic liver diseases and with the dose of contrast medium based on body surface area. Jpn J Radiol. 2015;33(4):194\u2013200. https:\/\/doi.org\/10.1007\/s11604-015-0398-1.","journal-title":"Jpn J Radiol"},{"issue":"5","key":"895_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.2214\/ajr.173.5.10541087","volume":"173","author":"O Vignaux","year":"1999","unstructured":"Vignaux O, Legmann P, Coste J, Hoeffel C, Bonnin A. Cirrhotic liver enhancement on dual-phase helical CT: comparison with noncirrhotic livers in 146 patients. AJR Am J Roentgenol. 1999;173(5):1193\u20137. https:\/\/doi.org\/10.2214\/ajr.173.5.10541087.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"895_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2021.100347","volume":"23","author":"Y Inokuchi","year":"2021","unstructured":"Inokuchi Y, Uematsu M, Takashina T. Diagnostic accuracy of the attenuation value in abdominal contrast enhanced dynamic multi-detector-row computed tomography for esophageal varices in patients with liver cirrhosis. Eur J Radiol Open. 2021;23(8): 100347. https:\/\/doi.org\/10.1016\/j.ejro.2021.100347.","journal-title":"Eur J Radiol Open"},{"key":"895_CR8","first-page":"1","volume":"1","author":"CG Child","year":"1964","unstructured":"Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1\u201385.","journal-title":"Major Probl Clin Surg"},{"key":"895_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Belhane S, Kagebayashi C, Satomura S, Teng M, Reeves H, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33:550\u20138. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151.","journal-title":"J Clin Oncol"},{"issue":"3","key":"895_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000452846","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Kumada T, Kudo M, Hirooka M, Tsuji K, Itobayashi E, et al. Albumin-Bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan Society of Hepatology: a comparison with the liver damage and child-pugh classifications. Liver Cancer. 2017;6(3):204\u201315. https:\/\/doi.org\/10.1159\/000452846.","journal-title":"Liver Cancer"},{"key":"895_CR11","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jamcollsurg.2019.12.007","volume":"230","author":"AM Fagenson","year":"2020","unstructured":"Fagenson AM, Gleeson EM, Pitt HA, Lau KN. Albumin-bilirubin score vs model for end-stage liver disease in predicting post-hepatectomy outcomes. J Am Coll Surg. 2020;230:637\u201345. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2019.12.007.","journal-title":"J Am Coll Surg"},{"key":"895_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/bjs.10095","volume":"103","author":"YY Wang","year":"2016","unstructured":"Wang YY, Zhong JH, Su ZY, Huang JF, Lu SD, Xiang BD, et al. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma. Br J Surg. 2016;103:725\u201334. https:\/\/doi.org\/10.1002\/bjs.10095.","journal-title":"Br J Surg"},{"key":"895_CR13","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.transproceed.2020.01.020","volume":"52","author":"K Tai","year":"2020","unstructured":"Tai K, Kuramitsu K, Kido M, Tanaka M, Komatsu S, Awazu M, et al. Impact of albumin-bilirubin score on short- and long-term survival after living- donor liver transplantation: a retrospective study. Transpl Proc. 2020;52:910\u20139. https:\/\/doi.org\/10.1016\/j.transproceed.2020.01.020.","journal-title":"Transpl Proc"},{"key":"895_CR14","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/jso.25721","volume":"120","author":"A Kornberg","year":"2019","unstructured":"Kornberg A, Witt U, Schernhammer M, Kornberg J, Muller K, Friess H, et al. The role of preoperative albumin-bilirubin grade for oncological risk stratification in liver transplant patients with hepatocellular carcinoma. J Surg Oncol. 2019;120:1126\u201336. https:\/\/doi.org\/10.1002\/jso.25721.","journal-title":"J Surg Oncol"},{"key":"895_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.20892\/j.issn.2095-3941.2018.0486","volume":"16","author":"C An","year":"2019","unstructured":"An C, Li X, Yu X, Cheng Z, Han Z, Liu F, et al. Nomogram based on albumin-bilirubin grade to predict outcome of the patients with hepatitis C virus-related hepatocellular carcinoma after microwave ablation. Cancer Biol Med. 2019;16:797\u2013810. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2018.0486.","journal-title":"Cancer Biol Med"},{"issue":"6","key":"895_CR16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/cancers11060879","volume":"11","author":"M Antkowiak","year":"2019","unstructured":"Antkowiak M, Gabr A, Das A, Ali R, Kulik L, Ganger D, et al. Prognostic role of albumin, bilirubin, and ALBI scores: analysis of 1000 patients with hepatocellular carcinoma undergoing radioembolization. Cancers (Basel). 2019;11(6):879. https:\/\/doi.org\/10.3390\/cancers11060879.","journal-title":"Cancers (Basel)"},{"key":"895_CR17","doi-asserted-by":"publisher","first-page":"840","DOI":"10.21037\/jgo.2018.05.14","volume":"9","author":"H Mohammadi","year":"2018","unstructured":"Mohammadi H, Abuodeh Y, Jin W, Frakes J, Friedman M, Biebel B, et al. Using the albumin-bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma. J Gastrointest Oncol. 2018;9:840\u20136. https:\/\/doi.org\/10.21037\/jgo.2018.05.14.","journal-title":"J Gastrointest Oncol"},{"key":"895_CR18","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/jgh.14564","volume":"34","author":"T Tada","year":"2019","unstructured":"Tada T, Kumada T, Toyoda H, Tsuji K, Hiraoka A, Michitaka K, et al. Impact of albumin- bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: an analysis using time- dependent receiver operating characteristic. J Gastroenterol Hepatol. 2019;34:1066\u201373. https:\/\/doi.org\/10.1111\/jgh.14564.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"895_CR19","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/cancers11070952","volume":"11","author":"K Ueshima","year":"2019","unstructured":"Ueshima K, Nishida N, Hagiwara S, Aoki T, Minami T, Chishina H, et al. Impact of baseline ALBI grade on the outcomes of hepatocellular carcinoma patients treated with lenvatinib: a multicenter study. Cancers (Basel). 2019;11(7):952. https:\/\/doi.org\/10.3390\/cancers11070952.","journal-title":"Cancers (Basel)"},{"key":"895_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/imj.12590","volume":"45","author":"S Bloom","year":"2015","unstructured":"Bloom S, Kemp W, Lubel J. Portal hypertension: pathophysiology, diagnosis and management. Intern Med J. 2015;45:16\u201326. https:\/\/doi.org\/10.1111\/imj.12590.","journal-title":"Intern Med J"},{"key":"895_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.20993","volume":"43","author":"Y Iwakiri","year":"2006","unstructured":"Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:121\u201331. https:\/\/doi.org\/10.1002\/hep.20993.","journal-title":"Hepatology"},{"issue":"24","key":"895_CR22","doi-asserted-by":"publisher","first-page":"9682","DOI":"10.3390\/ijms21249682","volume":"21","author":"L Shojaie","year":"2020","unstructured":"Shojaie L, Iorga A, Dara L. Cell death in liver diseases: a review. Int J Mol Sci. 2020;21(24):9682. https:\/\/doi.org\/10.3390\/ijms21249682.","journal-title":"Int J Mol Sci"},{"key":"895_CR23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10637-015-0292-9","volume":"33","author":"S Ogasawara","year":"2015","unstructured":"Ogasawara S, Chiba T, Ooka Y, Suzuki E, Kanogawa N, Saito T, et al. Liver function assessment according to the Albumin-Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma. Invest New Drugs. 2015;33:1257\u201362. https:\/\/doi.org\/10.1007\/s10637-015-0292-9.","journal-title":"Invest New Drugs"},{"key":"895_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.4269\/ajtmh.19-0129","volume":"101","author":"K Fujita","year":"2019","unstructured":"Fujita K, Nomura T, Morishita A, Oura K, Yoneyama H, Kobara H, et al. Albumin-bilirubin score differentiates liver fibrosis stage and hepatocellular carcinoma incidence in chronic hepatitis b virus infection: a retrospective cohort study. Am J Trop Med Hyg. 2019;101:220\u20135. https:\/\/doi.org\/10.4269\/ajtmh.19-0129.","journal-title":"Am J Trop Med Hyg"},{"key":"895_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/hepr.13333","volume":"49","author":"K Fujita","year":"2019","unstructured":"Fujita K, Oura K, Yoneyama H, Shi T, Takuma K, Nakahara M, Tadokoro T, Nomura T, Morishita A, Tsutsui K, Himoto T, Masaki T. Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res. 2019;49:731\u201342. https:\/\/doi.org\/10.1111\/hepr.13333.","journal-title":"Hepatol Res"}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-025-00895-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T08:03:01Z","timestamp":1748073781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-025-00895-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1007\/s12194-025-00895-1","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"type":"print","value":"1865-0333"},{"type":"electronic","value":"1865-0341"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"24 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Research Ethics Committee of The Edogawa Hospital approval was obtained (20210709-31).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}